300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Mobile
Education
Automotive
Sports
Hospitality
Legal
eSports
Biotechnology
Construction
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Infrastructure
Cannabis
Medical
LGBT
Celebrity
Recruiting
Climate
Mobile Apps
Life Science
Web3
Wine and Spirits
Music
Food and Beverage
Art
Publishing
Manufacturing
Digital Media
Real Estate
FinTech
Sporting Goods
Finance
Financial Services
Franchise
Social Media
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Tajikistan
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Madagascar
Isle of Man
Pakistan
Romania
Oman
Poland
Puerto Rico
Sudan
Cameroon
Guernsey
Andorra
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
Iraq
United Kingdom
Mali
Latvia
Portugal
Malaysia
Sierra Leone
Rwanda
El Salvador
Senegal
Philippines
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Cyprus
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Qatar
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Hungary
Italy
Belarus
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Kazuhiro Sakakibara, Senior Associate at ANRI

Kazuhiro Sakakibara

Senior Associate @ ANRI

Kazuhiro Sakakibara is a Series A investor at ANRI focused on Health Care and Medical. Kazuhiro Sakakibara is the Senior Associate at ANRI.

Total investments:
5
Last investment:
Lead investor:
0%

Last updated:

Industries Kazuhiro Sakakibara invests in

Health CareMedicalBiotechnologyTherapeuticsPharmaceutical

Stages Kazuhiro Sakakibara invests in

Series ASeedPre-Seed

Countries Kazuhiro Sakakibara invests in

Japan

Investment Focus

Industry

  • Health Care 3 (60%)
  • Medical 2 (40%)
  • Biotechnology 2 (40%)
  • Therapeutics 1 (20%)
  • Pharmaceutical 1 (20%)
See all 6 industries →

Stage

  • Series A 3 (60%)
  • Seed 1 (20%)
  • Pre-Seed 1 (20%)

Investments

CompanyDescriptionRoundLinks
Arrowsmith Arrowsmith
Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance. $6.5M / Series A / Jun 22, 2026
xCARE xCARE
xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries. $3.7M / Series A / Jun 08, 2026
FerroptoCure FerroptoCure
FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases. $3.1M / Series A / Sep 19, 2025
xCARE xCARE
xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries. $862.5K / Seed / Feb 13, 2024
Ruten Ruten
Ruten is a brain-machine interface company that specializes in reconstructive treatments for infeasible and ineffective conditions. $500K / Pre-Seed / Nov 01, 2023

Co-Investors

ANRI

About ANRI

VC Fund · Tokyo, Japan

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

ANRI Contacts

NameEmailPhoneSocials
Anri Samata
Anri Samata Partner; Founder & General Partner
Anri Samata
Anri Samata Founder & General Partner
Junichiro Kono
Junichiro Kono General Partner
Kazuhiro Sakakibara
Kazuhiro Sakakibara Senior Associate
Masahiro Sameshima
Masahiro Sameshima General Partner

Sign up to unlock verified contacts

Unlock Contacts
Open ANRI full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Mobile
Education
Automotive
Sports
Hospitality
Legal
eSports
Biotechnology
Construction
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Infrastructure
Cannabis
Medical
LGBT
Celebrity
Recruiting
Climate
Mobile Apps
Life Science
Web3
Wine and Spirits
Music
Food and Beverage
Art
Publishing
Manufacturing
Digital Media
Real Estate
FinTech
Sporting Goods
Finance
Financial Services
Franchise
Social Media
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Tajikistan
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Madagascar
Isle of Man
Pakistan
Romania
Oman
Poland
Puerto Rico
Sudan
Cameroon
Guernsey
Andorra
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
Iraq
United Kingdom
Mali
Latvia
Portugal
Malaysia
Sierra Leone
Rwanda
El Salvador
Senegal
Philippines
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Cyprus
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Qatar
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Hungary
Italy
Belarus
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Kazuhiro Sakakibara invest in?

Kazuhiro Sakakibara invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Kazuhiro Sakakibara last invest?

The most recent investment recorded for Kazuhiro Sakakibara closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Kazuhiro Sakakibara Kazuhiro Sakakibara Find email